Co-axial hydrogel spinning for facile biofabrication of prostate cancer-like 3D models

last updated: 2024-03-26
ProjectCOMET :: publications list
TitleCo-axial hydrogel spinning for facile biofabrication of prostate cancer-like 3D models
Publication TypePapers in Scientific Journals
Year of Publication2024
AuthorsGuimarães C. F., Liu S., Wang J., Purcell E., Ozedirne T., Ren T., Aslan M., Yin Q., Reis R. L., Stoyanova T., and Demirci U.

Glandular cancers are amongst the most prevalent types of cancer, which can develop in many different organs, presenting challenges in their detection as well as high treatment variability and failure rates. For that purpose, anticancer drugs are commonly tested in cancer cell lines grown in 2D tissue culture on plastic dishes in vitro, or in animal models in vivo. However, 2D culture models diverge significantly from the 3D characteristics of living tissues and animal models require extensive animal use and time. Glandular cancers, such as prostate cancer—the second leading cause of male cancer death—typically exist in co-centrical architectures where a cell layer surrounds an acellular lumen. Herein, this spatial cellular position and 3D architecture, containing dual compartments with different hydrogel materials, is engineered using a simple co-axial nozzle setup, in a single step utilizing prostate as a model of glandular cancer. The resulting hydrogel soft structures support viable prostate cancer cells of different cell lines and enable over-time maturation into cancer-mimicking aggregates surrounding the acellular core. The biofabricated cancer mimicking structures are then used as a model to predict the inhibitory efficacy of the poly ADP ribose polymerase inhibitor, Talazoparib, and the antiandrogen drug, Enzalutamide, in the growth of the cancer cell layer. Our results show that the obtained hydrogel constructs can be adapted to quickly obtain 3D cancer models which combine 3D physiological architectures with high-throughput screening to detect and optimize anti-cancer drugs in prostate and potentially other glandular cancer types.

Date Published2024-02-20
PublisherIOP Publisher
Keywords3D in vitro models, biofabrication, Co-axial, Drug testing, POLYSACCHARIDES
RightsembargoedAccess (2 Years)
Peer reviewedyes

Back to top